1-9 of 9
filgrastim-sndz
Close
Sort by
Journal Articles

Comparison of Pegfilgrastim and Filgrastim to Prevent Neutropenic Fever during Consolidation with High Dose Cytarabine for Acute Myeloid Leukemia

Evan Field, Paolo F Caimi, MD, Brenda Cooper, MD, Jane Little, MD, Ehsan Malek, MD, Leland Metheny, MD, Marcos de Lima, MD, Pingfu Fu, Ben Tomlinson, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1404.
https://doi.org/10.1182/blood-2018-99-118336
Published: 2018
Journal Articles

Cost-Effective Use of White Blood Cell Growth Factors in the Veterans Administration

Kevin Knopf, MD, William Hrureshky, Bryan Love, Leann Norris, Charles L. Bennett, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4761.
https://doi.org/10.1182/blood-2018-99-119724
Published: 2018
Journal Articles

Trends in Neutropenia-Related Hospitalization in Older Patients with Non-Hodgkin Lymphoma (NHL) Receiving Myelosuppressive Chemotherapy in the United States: 1995-2015

Shuling Li, PhD, Jiannong Liu, PhD, Haifeng Guo, MS, Prasad L Gawade, MBBS, PhD, Christopher Kim, PhD, Mark E. Bensink, PhD MSc, MD, David Chandler, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2308.
https://doi.org/10.1182/blood-2018-99-115213
Published: 2018
Journal Articles

Plinabulin, a Novel Small Molecule in Development for Chemotherapy-Induced-Neutropenia (CIN) Prevention, Mobilizes CD34+ Cells through a Mechanism of Action (MoA) Different from G-CSF and from CXCR4 Inhibition

Douglas W. Blayney, MD, Ene Ette, PhD, Stephan Ogenstad, PhD, Yuankai Shi, MD PhD, Lihua Du, Kenneth Lloyd, PhD, Lan Huang, PhD, Ramon Mohanlal, PhD MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2068.
https://doi.org/10.1182/blood-2018-99-113569
Published: 2018
Journal Articles

Comparative Cost-Efficiency Analysis of Granulocyte Colony-Stimulating Factors for Use in Chemotherapy Patients in the United States

Elizabeth James, Holly Trautman, Erika Szabo, Boxiong Tang, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4667.
https://doi.org/10.1182/blood.V130.Suppl_1.4667.4667
Published: 2017
Journal Articles

Budget Impact Analysis of Switching Chemotherapy Patients Using Granulocyte Colony-Stimulating Factors (G-CSFs) from Pegfilgrastim to Short-Acting G-CSFs in the United States

Elizabeth James, Holly Trautman, Erika Szabo, Boxiong Tang, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4668.
https://doi.org/10.1182/blood.V130.Suppl_1.4668.4668
Published: 2017
Journal Articles

Expanded Access to Obinutuzumab from Cost-Savings Generated By Biosimilar Filgrastim-Sndz in the Prophylaxis of Chemotherapy-Induced (Febrile) Neutropenia: US Simulation Study

Ali McBride, PharmD,MS, Kim Campbell, Mohan Bikkina, Karen MacDonald, Ivo Abraham, PhD RN, Sanjeev Balu
Journal: Blood
Blood (2017) 130 (Supplement 1): 3380.
https://doi.org/10.1182/blood.V130.Suppl_1.3380.3380
Published: 2017
Journal Articles

Budget Impact Analysis of Treating Chemotherapy Patients with Health Care Provider-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Holly Trautman, Erika Szabo, Francesco Lo-Coco, Elizabeth James, Susan Gabriel, Jifang Zhou, Ashutosh Pathak, Boxiong Tang
Journal: Blood
Blood (2016) 128 (22): 2407.
https://doi.org/10.1182/blood.V128.22.2407.2407
Published: 2016
Journal Articles

Budget Impact Analysis of Treating Chemotherapy Patients with Patient-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Holly Trautman, Erika Szabo, Francesco Lo-Coco, Elizabeth James, Susan Gabriel, Jifang Zhou, Ashutosh Pathak, Boxiong Tang
Journal: Blood
Blood (2016) 128 (22): 4786.
https://doi.org/10.1182/blood.V128.22.4786.4786
Published: 2016